论文部分内容阅读
目的探讨氨氯地平阿托伐他汀钙片治疗高血压合并冠心病临床疗效。方法以2014年3月至2016年3月我院所收治的94例高血压合并冠心病患者作为研究对象,对比患者在接受氨氯地平片治疗(对照组,47例)与氨氯地平阿托伐他汀钙片治疗(观察组,47例)前后的血压、血脂变化情况。结果观察组患者在接受上述治疗后,其收缩压为(125±5)mmHg,舒张压为(70±4)mmHg;TG为(1.9±0.56)mmol/L,TC为(3.53±1.13)mmol/L,LDL-C为(1.69±0.52)mmol/L,HDL-C为(1.10±0.26)mmol/L,均明显低于对照组且组间差异明显具有统计学意义(P<0.05)。结论临床上在治疗高血压合并冠心病时,选用氨氯地平阿托伐他汀钙片治疗,能够使患者的血压及血脂水平得到显著的改善,应予以大力推广。
Objective To investigate the clinical efficacy of amlodipine atorvastatin calcium in patients with hypertension and coronary heart disease. Methods 94 patients with hypertension and coronary heart disease admitted to our hospital from March 2014 to March 2016 were enrolled in this study. Patients in control group received amlodipine (control group, n = 47) and amlodipine The changes of blood pressure and blood lipid before and after treatment with statins of statins (observation group, n = 47). Results The patients in observation group had systolic pressure of (125 ± 5) mmHg and diastolic pressure of (70 ± 4) mmHg after receiving the above treatment. The TG was (1.9 ± 0.56) mmol / L and TC was (3.53 ± 1.13) mmol (1.69 ± 0.52) mmol / L for LDL-C and (1.10 ± 0.26) mmol / L for HDL-C, which were significantly lower than those of the control group (P <0.05). Conclusion In the treatment of hypertension with coronary heart disease, the treatment of amlodipine with atorvastatin calcium can significantly improve the blood pressure and blood lipid levels of patients and should be vigorously promoted.